Dimetilanilin monooksigenaza (N-oksid-formirajuća) 2 je enzim koji je kod ljudi kodiran FMO2genom.[4][5][6]
Monooksigenaze koje sarže flavin su NADPH zavisni enzimi koji katalizuju oksidaciju mnogih lekova i ksenobiotika. Kod većine sisara, monooksigenaze koje sadrže flavin katalizuju N-oksidaciju primarnih alkilamina putem N-hidroksilaminskih intermedijera. Međutim, kod ljudi ovaj enzim je okrnjen i verovatno se brzo ralaže. Protein kodiran ovim genom predstavlja skraćenu formu is stoga nema kataličko dejstvo. Objavljeno je da je kod afričkih amerikanaca funkcionalni alil prisutan, ali evidencija u vidu sekvence nije dostupna u prilog toj tvrdnji. Ovaj gen je lociran u klasteru sa FMO1, FMO3, i FMO4 genima na hromozomu 1.[6]
^Dolphin CT, Beckett DJ, Janmohamed A, Cullingford TE, Smith RL, Shephard EA, Phillips IR (1998). „The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein”. J Biol Chem. 273 (46): 30599—607. PMID9804831. doi:10.1074/jbc.273.46.30599.
Phillips IR, Dolphin CT, Clair P, et al. (1995). „The molecular biology of the flavin-containing monooxygenases of man.”. Chem. Biol. Interact. 96 (1): 17—32. PMID7720101. doi:10.1016/0009-2797(94)03580-2.
Lawton MP, Cashman JR, Cresteil T, et al. (1994). „A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities.”. Arch. Biochem. Biophys. 308 (1): 254—7. PMID8311461. doi:10.1006/abbi.1994.1035.
McCombie RR, Dolphin CT, Povey S, et al. (1996). „Localization of human flavin-containing monooxygenase genes FMO2 and FMO5 to chromosome 1q.”. Genomics. 34 (3): 426—9. PMID8786146. doi:10.1006/geno.1996.0308.
Bonaldo MF, Lennon G, Soares MB (1997). „Normalization and subtraction: two approaches to facilitate gene discovery.”. Genome Res. 6 (9): 791—806. PMID8889548. doi:10.1101/gr.6.9.791.
Whetstine JR, Yueh MF, McCarver DG, et al. (2000). „Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: detection of expressed protein in African-Americans.”. Toxicol. Appl. Pharmacol. 168 (3): 216—24. PMID11042094. doi:10.1006/taap.2000.9050.
Krueger SK, Martin SR, Yueh MF, et al. (2002). „Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.”. Drug Metab. Dispos. 30 (1): 34—41. PMID11744609. doi:10.1124/dmd.30.1.34.
Furnes B, Feng J, Sommer SS, Schlenk D (2003). „Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans.”. Drug Metab. Dispos. 31 (2): 187—93. PMID12527699. doi:10.1124/dmd.31.2.187.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). „Complete sequencing and characterization of 21,243 full-length human cDNAs.”. Nat. Genet. 36 (1): 40—5. PMID14702039. doi:10.1038/ng1285.
Gregory SG, Barlow KF, McLay KE, et al. (2006). „The DNA sequence and biological annotation of human chromosome 1.”. Nature. 441 (7091): 315—21. PMID16710414. doi:10.1038/nature04727.